ABOUT THE QUALITY OF BRAND-NAME DRUGS FROM CANADA…

Whenever American consumers have the opportunity to save money – especially in the huge amounts possible through direct importation of their personal prescription drugs – there are those who have obvious incentives to discourage such actions. Among others, such detractors have been some US distributors of pharmaceuticals, large multinationals and other pharmaceutical manufacturers whose products are sold for much less outside the US. To protect their excessive US prices and illegitimate profits, one subversive tactic of these special-interest entities has been to directly disparage and/or to set up and fund "front" organizations or individuals to cast doubts on the quality and relative safety of the imported products.

In response to disinformation and misinformation campaigns that may have been mounted by such entities, their affiliates, and their lackeys, Expedite-Rx issues the following challenge:

"The e-mail address for Expedite-Rx is  administrator@expedite-rx.com . If any manufacturer or distributor of brand-name pharmaceutical products will send to that site validatable documentation that the product(s) they manufacture or distribute for consumption by Canadian citizens is/are inferior to the product(s) that they manufacture or distribute for consumption by citizens of the United States, upon such validation, Expedite-Rx will delete any such "proven inferior" product(s) from the list of drugs deemed to be eligible for importation. However, Expedite-Rx reserves the right to make such information public - if any should ever be submitted."

ERXchallenge